Immunovant Inc (NASDAQ:IMVT)
| 15.27 Delayed Data As of Mar 24 |  -0.35 / -2.24%Today’s Change | 3.15 Today|||52-Week Range 20.24 | -13.97% Year-to-Date |
Latest IMVT News | Press Releases
No recent news for Immunovant Inc.
Today’s Trading
| Previous close | 15.62 |
| Today’s open | 15.47 |
| Day’s range | 14.86 - 15.47 |
| Volume | 37,694 |
| Average volume (3 months) | 1,049,659 |
| Market cap | $2.0B |
Data as of 3:59pm ET, 03/24/2023
Growth & Valuation
| Earnings growth (last year) | -16.73% |
| Earnings growth (this year) | -10.51% |
| Earnings growth (next 5 years) | +3.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 3.80 |
Competitors
Data as of 4:00pm ET, 03/24/2023
Financials
| Next reporting date | June 7, 2023 |
| EPS forecast (this quarter) | -$0.40 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$156.7M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters --, -- |
Forecasts
